INTRODUCTIONBone metabolic diseases develop when there is an imbalance between the formation and resorption of bone that depends on the interaction between osteoblasts and osteoclasts. Osteoporosis is the most common bone metabolic disease in adults, especially among the elderly, which is characterized by compromised bone strength that predisposes individuals to an increased risk of fracture. Most current pharmacological approaches focus on inhibiting bone resorption in patients with osteoporosis or at risk of developing the disease. However, researchers have also provided evidence on dietary components that can optimize bone mass and stimulate bone formation. Thus, Habauzit & Horcajada reported that phytonutrients in our diet, especially polyphenols, can act on both osteoblasts and osteoclasts to modulate bone metabolism.Bone formation involves a complex series of events, including osteoprogenitor cell proliferation and differentiation, which eventually result in the formation of a mineralized extracellular matrix. Numerous cytokines, hormones and growth factors control bone formation by regulating osteoblast cell proliferation and differentiation. Bone is a dynamic tissue under continuous remodelling process where osteoblasts, which derive from undifferentiated pluripotent mesenchymal cells, are responsible for bone development. It has been described that osteoblasts have immunological functions because of the expression of markers of antigen‐presenting capacity (CD54, CD80,
European Journal of Clinical Investigation – Wiley
Published: Jan 1, 2018
Keywords: ; ; ; ;
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
All the latest content is available, no embargo periods.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud